Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The existing evidence base comes from preclinical (animal) studies conducted primarily at Washington State University, where the compound was developed and patented for potential use in Alzheimer's disease
Mounjaro (tirzepatide) prescribing information
Both peptides show systemic bioactivity but act most strongly at sites of injury or inflammation
Neither peptide in this blend is approved by the FDA for human or veterinary use
US$ 27.79
US$ 23.29
US$ 24.97
US$ 24.13
US$ 25.22
US$ 26.78
US$ 29.82
